BCM
BML Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.4M | Hold |
7,609,812
| – | – | 20.73% | 1 |
|
|
2025
Q1 | $22.8M | Buy |
7,609,812
+1,500
| +0% | +$4.49K | 18.41% | 1 |
|
|
2024
Q4 | $25.5M | Buy |
7,608,312
+958,312
| +14% | +$3.21M | 15.83% | 3 |
|
|
2024
Q3 | $22.3M | Buy |
6,650,000
+274,379
| +4% | +$919K | 13.11% | 3 |
|
|
2024
Q2 | $21.1M | Buy |
6,375,621
+838,911
| +15% | +$2.78M | 15.06% | 2 |
|
|
2024
Q1 | $22.4M | Buy |
5,536,710
+74,631
| +1% | +$302K | 14.75% | 2 |
|
|
2023
Q4 | $16.7M | Buy |
5,462,079
+662,079
| +14% | +$2.02M | 12.62% | 3 |
|
|
2023
Q3 | $14.4M | Buy |
4,800,000
+2,563,761
| +115% | +$7.69M | 13.22% | 3 |
|
|
2023
Q2 | $8.36M | Buy |
+2,236,239
| New | +$8.36M | 7.52% | 4 |
|